Concurrent Nab-paclitaxel and Radiotherapy: Novel Radiosensitization for Borderline Resectable or Unresectable Pancreatic Cancer

This study evaluates the toxicity and tumor response with concurrent nab-paclitaxel chemoradiotherapy (CRT) compared with standard (5-fluorouracil or gemcitabine) CRT. MATERIALS AND METHODS: Fifty patients with borderline resectable or unresectable pancreatic adenocarcinoma from 2014 to 2017 were di...

Descripción completa

Detalles Bibliográficos
Autores principales: Arscott, William T., Nead, Kevin T., Bear, Adham, Venigalla, Sriram, Shabason, Jacob, Lukens, John N., Plastaras, John P., Wojcieszynski, Andrzej, Metz, James, O’Hara, Mark, Reiss, Kim A., Teitelbaum, Ursina, Loaiza-Bonilla, Arturo, Drebin, Jeffrey, Lee, Major K., Shroff, Stuti G., Ben-Josef, Edgar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Original Articles: Gastrointestinal
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404955/
https://www.ncbi.nlm.nih.gov/pubmed/34310350
http://dx.doi.org/10.1097/COC.0000000000000854

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404955/
https://www.ncbi.nlm.nih.gov/pubmed/34310350
http://dx.doi.org/10.1097/COC.0000000000000854

Ejemplares similares